153 related articles for article (PubMed ID: 9187468)
1. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
Emmert C; Rassler J; Köhler U
Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of ureteral obstruction in primary cervical cancer.
Lee SK; Jones HW
Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
4. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
5. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
6. Maintaining quality of life after palliative diversion for malignant ureteral obstruction.
Markowitz DM; Wong KT; Laffey KJ; Bixon R; Nagler HM; Martin EC
Urol Radiol; 1989; 11(3):129-32. PubMed ID: 2480679
[TBL] [Abstract][Full Text] [Related]
7. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
8. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous nephrostomy for bilateral ureteric obstruction in carcinoma of the cervix. A case report.
de Franca Martins A; Graubard Z; Ballot DE
S Afr Med J; 1987 May; 71(10):661-2. PubMed ID: 3576393
[TBL] [Abstract][Full Text] [Related]
10. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
Bell DG; Fischer MA
Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
[TBL] [Abstract][Full Text] [Related]
11. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
Gasparini M; Carroll P; Stoller M
Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
[TBL] [Abstract][Full Text] [Related]
12. Win or lose? Percutaneous nephrostomy for a terminal-stage cervical-cancer patient featuring obstructive uropathy.
Chang HL; Lim HW; Su FH; Tsai ST; Wang YW
J Palliat Care; 2006; 22(1):57-60. PubMed ID: 16689418
[No Abstract] [Full Text] [Related]
13. Use of percutaneous nephrostomy in malignant ureteric obstruction.
Chapman ME; Reid JH
Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
[TBL] [Abstract][Full Text] [Related]
14. Palliative urinary diversion in carcinoma of the cervix.
Meyer JE; Green TH; Yatsuhashi M
Obstet Gynecol; 1980 Jan; 55(1):95-8. PubMed ID: 6153241
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
16. [Endoluminal therapy for bilateral malignant ureteric obstruction].
Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer: Renal complications and survival after percutaneous nephrostomy.
Souza AC; Souza AN; Kirsztajn R; Kirsztajn GM
Rev Assoc Med Bras (1992); 2016; 62(3):255-61. PubMed ID: 27310550
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous urinary drainage and ureteric stenting in malignant disease.
Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
[TBL] [Abstract][Full Text] [Related]
19. Mortality and complications associated with percutaneous nephrostomy in patients with ureteral obstruction related to advanced cervical cancer.
Cardona AF; Garzón JR; Burgos E; Abenoza LM; Cortés JA; Ramos PL
J Palliat Care; 2006; 22(4):315. PubMed ID: 17263063
[No Abstract] [Full Text] [Related]
20. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
Ekici S; Sahin A; Ozen H
J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
